South Austin Cancer Center
Austin, TX
Accepting patients
GCO12F CAR-T
A Phase 1b/2 Study of GC012F (AZD0120), a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell Maturation Antigen (BCMA) in Subjects With Relapsed/Refractory Multiple Myeloma
- CAR T Cell
- BCMA
- CD19
- Phase 1/2